<DOC>
	<DOCNO>NCT00507403</DOCNO>
	<brief_summary>There great individual variability pharmacokinetic infliximab patient treat ankylose spondylitis ( AS ) . Moreover , patient treatment methotrexate ( MTX ) , others . Thus , aim study assess effect MTX pharmacokinetic property infliximab 30 patient treat AS , 15 MTX , 15 without .</brief_summary>
	<brief_title>Infliximab Methotrexate Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Ankylosing spondylitis Needing antiTNF drug Contraindications antiTNF drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>